{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:42:21Z","timestamp":1761057741426,"version":"3.30.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1378\/chest.116.5.1304","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"1304-1312","source":"Crossref","is-referenced-by-count":11,"title":["A Controlled Trial of Chlorofluorocarbon-Free Triamcinolone Acetonide Inhalation Aerosol in the Treatment of Adult Patients With Persistent Asthma"],"prefix":"10.1016","volume":"116","author":[{"given":"Michael","family":"Welch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.116.5.1304_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0091-6749(98)70349-5","article-title":"A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 \u03bcg per day) for the treatment of patients with mild-to-moderate asthma","volume":"101","author":"Bernstein","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.116.5.1304_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.81.1.20","article-title":"Efficacy and safety of triamcinolone acetonide aerosol in chronic asthma: results of a multicenter, short-term controlled and long-term open study","volume":"81","author":"Bernstein","year":"1982","journal-title":"Chest"},{"key":"10.1378\/chest.116.5.1304_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/02770908209104767","article-title":"Control of asthma with triamcinolone acetonide aerosol inhalations at 12 hour intervals","volume":"19","author":"Falliers","year":"1982","journal-title":"J Asthma"},{"key":"10.1378\/chest.116.5.1304_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0091-6749(78)90082-9","article-title":"Treatment of asthma in children with triamcinolone acetonide aerosol","volume":"62","author":"Sly","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.116.5.1304_bib5","first-page":"538","article-title":"Treatment of asthma with triamcinolone acetonide delivered by aerosol","volume":"109","author":"Williams","year":"1974","journal-title":"Am Rev Respir Dis"},{"issue":"suppl 1","key":"10.1378\/chest.116.5.1304_bib6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1089\/jam.1995.8.Suppl_1.S-13","article-title":"Montreal protocol and essential use exemptions","volume":"8","author":"D'Souza","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1378\/chest.116.5.1304_bib7","first-page":"26","article-title":"CPMP on possible alternatives of CFCs","volume":"1943","year":"1994","journal-title":"Scrip"},{"key":"10.1378\/chest.116.5.1304_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.93.03050495","article-title":"Metered dose pressurized aerosols and the ozone layer","volume":"3","author":"Newman","year":"1990","journal-title":"Eur Respir J"},{"issue":"suppl 1","key":"10.1378\/chest.116.5.1304_bib9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1089\/jam.1995.8.Suppl_1.S-3","article-title":"CFCs, their replacements and the ozone layer","volume":"8","author":"Noakes","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1378\/chest.116.5.1304_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.2042-7158.1996.tb05980.x","article-title":"Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects","volume":"48","author":"Harrison","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1378\/chest.116.5.1304_bib11","first-page":"6940","article-title":"Dosage unit sampling for metered-dose inhalers","volume":"24","author":"United States Pharmacopeial Convention","year":"1998","journal-title":"Pharmacopeial Forum"},{"issue":"suppl 39","key":"10.1378\/chest.116.5.1304_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.1997.tb05047.x","article-title":"A comparison of the efficacy and safety of inhaled corticosteroids in asthma","volume":"52","author":"Pedersen","year":"1997","journal-title":"Allergy"},{"key":"10.1378\/chest.116.5.1304_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1378\/chest.112.3.597","article-title":"Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma","volume":"112","author":"Welch","year":"1997","journal-title":"Chest"},{"key":"10.1378\/chest.116.5.1304_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1398-9995.1988.tb00415.x","article-title":"A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma","volume":"43","author":"Johannson","year":"1988","journal-title":"Allergy"},{"key":"10.1378\/chest.116.5.1304_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0091-6749(94)90174-0","article-title":"Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma","volume":"94","author":"Chervinsky","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.116.5.1304_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199503303321307","article-title":"Inhaled glucocorticoids for asthma","volume":"332","author":"Barnes","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.116.5.1304_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm\/148.4_Pt_2.S1","article-title":"Efficacy and safety of inhaled corticosteroids in asthma","volume":"148","author":"Barnes","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.116.5.1304_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJM199108083250603","article-title":"Comparison of a \u03b22-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma","volume":"325","author":"Haahtela","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.116.5.1304_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1164\/ajrccm\/143.6.1317","article-title":"Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma","volume":"143","author":"Vathenen","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.116.5.1304_bib20","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0091-6749(96)70257-9","article-title":"A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis","volume":"97","author":"Day","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.116.5.1304_bib21","first-page":"409","article-title":"A placebo-controlled, double-blind comparison of topical versus systemic triamcinolone acetonide aqueous nasal spray in seasonal allergic rhinitis","volume":"10","author":"Gross","year":"1996","journal-title":"Am J Rhinol"},{"key":"10.1378\/chest.116.5.1304_bib22","first-page":"300","article-title":"Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis","volume":"64","author":"Spector","year":"1990","journal-title":"Ann Allergy"},{"issue":"suppl 28","key":"10.1378\/chest.116.5.1304_bib23","first-page":"434S","article-title":"HPA function in asthmatic adults after 12 months of treatment with Azmacort HFA-134a 75 mcg and Azmacort HFA-134a 225 mcg oral inhalers [abstract]","volume":"12","author":"Nelson","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.116.5.1304_bib24","first-page":"S325","article-title":"Comparison of triamcinolone acetonide HFA vs. CFC formulations on the short cosyntropin test in children [abstract]","volume":"99","author":"Caldwell","year":"1997","journal-title":"J Allergy Clin Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215516012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215516012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T22:09:13Z","timestamp":1734041353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215516012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["S0012369215516012"],"URL":"https:\/\/doi.org\/10.1378\/chest.116.5.1304","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}